The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The world's largest clinical research trial in hyperbaric medicine is taking place on the USF Campus right now, studying its impact on Traumatic Brain Injury.
The Slovak Spectator on MSN1h
Award-winning Slovak oncologist: It's all about trust between a doctor and patientYou worked abroad for several years. What did you gain from the experience? I had the opportunity to go to the Vienna School of Clinical Research, and later I worked in America. The former was a ...
Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...
Dr. Mrinal M Gounder emphasizes the complexity of breast cancer and the necessity for unique treatments for its many variants ...
A Professor of Paediatric Clinical Pharmacology, University of Ghana Medical School, Professor George Obeng Adjei, has advocated ...
Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...
UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...
The immediate impact for the medical sciences is unclear, but the symbolism is “very chilling,” one commentator says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback